Notice of Correction to Key Dates for PAR-18-020 "NCI Clinical and Translational Exploratory/Developmental Studies (R21)"

Notice Number: NOT-CA-18-023

Key Dates
Release Date: November 30, 2017

Related Announcements
PAR-18-020

Issued by
National Cancer Institute (NCI)

Purpose

This Notice corrects the Key Dates Section of Funding Opportunity (FOA) PAR-18-020 "NCI Clinical and Translational Exploratory/Developmental Studies (R21)".

The following Key Dates of the FOA have been corrected (in italics):

Part 1. Key Dates

Open Date (Earliest Submission Date):

Currently reads:
January 21, 2018

Should correctly read:
January 20, 2018

Application Due Date(s):

Currently reads:
July 19, 2018; October 18, 2018; February 21, 2019; June 19, 2019; October 17, 2019; February 20, 2020; June 19, 2020; October 17, 2020; February 20, 2021, by 5:00 PM local time of applicant organization.

Should correctly read:
February 20, 2018; June 19, 2018; October 17, 2018; February 20, 2019, by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s):

Currently reads:
July 19, 2018; November 22, 2018; March 22, 2019; July 19, 2019; November 22, 2019; March 22, 2020; July 19, 2020; November 22, 2020; March 22, 2021, by 5:00 PM local time of applicant organization.

Should correctly read:
March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2019, by 5:00 PM local time of applicant organization.

Scientific Merit Review:

Currently reads:
October 2018; February 2019; June 2019; October 2019; February 2020; June 2020; October 2020; February 2021; June 2021

Should correctly read:
June 2018; October 2018; February 2019; June 2019

Advisory Council Review:

Currently reads:
January 2019; May 2019; October 2019; January 2020; May 2020; October 2020; January 2021; May 2021; October 2021

Should correctly read:
October 2018; January 2019; May 2019; October 2019

Earliest Start Date:

Currently reads:
April 2019; August 2019; December 2019; April 2020; August 2020; December 2020; April 2021; August 2021; December 2021

Should correctly read:
December 2018; April 2019; July 2019; December 2019

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

William C. Timmer, Ph.D
National Cancer Institute (NCI)
Telephone: 240-276-6130
Email: william.timmer@nih.gov

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov